Kronik Ağrıda İntravenöz Lidokain Uygulamaları

Gordh T. Xylocain–a new local analgesic. Anaesthesia. 1949;4:4-9.

Gilbert CRA, Hanson IR, Brown AB, et al. Intravenous use of xylocaine. Anesthesia & Analgesia. 1951;30:301-313.

De Clive‐Lowe S, Desmond J, North J. Intravenous lignocaine anaesthesia. Anaesthesia. 1958;13:138-146.

Edwards TW, Habib F, Burney RG, et al. Intravenous lidocaine in the management of various chronic pain states: a review of 211 cases. Regional Anesthesia and Pain Medicine. 1985;10:1-6.

Bartlett EE, Hutaserani O. Xylocaine for the relief of postoperative pain. Anesthesia & Analgesia. 1961;40:296-304.

Iwane T, Maruyama M, Matsuki M, et al. Management of intractable pain in adiposis dolorosa with intravenous administration of lidocaine. Anesthesia & Analgesia. 1976;55:257-259.

Petersen P, Kastrup J, Zeeberg I, et al. Chronic pain treatment with intravenous lidocaine. Neurological Research. 1986;8:189-190.

Hermanns H, Hollmann MW, Stevens MF, et al. Molecular mechanisms of action of systemic lidocaine in acute and chronic pain: a narrative review. British journal of anaesthesia. 2019;123:335-349.

Rowland M, Thomson PD, Guichard A, et al. Disposition kinetics of lidocaine in normal subjects. Annals of the New York Academy of Sciences. 1971;179:383-398.

Bennett PN, Aarons LJ, Bending MR, et al. Pharmacokinetics of lidocaine and its deethylated metabolite: dose and time dependency studies in man. Journal of Pharmacokinetics and Biopharmaceutics. 1982;10:265-281.

Lirk P, Hollmann MW, Strichartz G. The science of local anesthesia: basic research, clinical application, and future directions. Anesthesia & Analgesia. 2018;126:1381-1392.

Tibbs GR, Posson DJ, Goldstein PA. Voltage-gated ion channels in the PNS: novel therapies for neuropathic pain? Trends in pharmacological sciences. 2016;37:522-542.

Leffler A, Reiprich A, Mohapatra DP, et al. Use-dependent block by lidocaine but not amitriptyline is more pronounced in tetrodotoxin (TTX)-Resistant Nav1. 8 than in TTX-sensitive Na+ channels. Journal of Pharmacology and Experimental Therapeutics. 2007;320:354-364.

Chevrier P, Vijayaragavan K, Chahine M. Differential modulation of Nav1. 7 and Nav1. 8 peripheral nerve sodium channels by the local anesthetic lidocaine. British journal of pharmacology. 2004;142:576-584.

Roza C, Laird JM, Souslova V, et al. The tetrodotoxin‐resistant Na+ channel Nav1. 8 is essential for the expression of spontaneous activity in damaged sensory axons of mice. The Journal of physiology. 2003;550:921-926.

Nakahira K, Oshita K, Itoh M, et al. Clinical Concentrations of local anesthetics bupivacaine and lidocaine differentially inhibit human Kir2. x inward rectifier k+ channels. Anesthesia & Analgesia. 2016;122:1038-1047.

Boroujerdi A, Kim HK, Lyu YS, et al. Injury discharges regulate calcium channel alpha-2-delta-1 subunit upregulation in the dorsal horn that contributes to initiation of neuropathic pain. Pain. 2008;139:358-366.

Lingamaneni R, Hemmings Jr H. Differential interaction of anaesthetics and antiepileptic drugs with neuronal Na+ channels, Ca2+ channels, and GABAA receptors. British journal of anaesthesia. 2003;90:199-211.

Docherty RJ, Ginsberg L, Jadoon S, et al. TRPA1 insensitivity of human sural nerve axons after exposure to lidocaine. Pain®. 2013;154:1569-1577.

Putrenko I, Schwarz SK. Lidocaine blocks the hyperpolarization-activated mixed cation current, I h, in rat thalamocortical neurons. The Journal of the American Society of Anesthesiologists. 2011;115:822-835.

Hahnenkamp K, Durieux M, Hahnenkamp A, et al. Local anaesthetics inhibit signalling of human NMDA receptors recombinantly expressed in Xenopus laevis oocytes: role of protein kinase C. British Journal of Anaesthesia. 2006;96:77-87.

Hollmann MW, Gross A, Jelacin N, et al. Local anesthetic effects on priming and activation of human neutrophils. The Journal of the American Society of Anesthesiologists. 2001;95:113-122.

Caracas HCPM, Maciel JVB, de Souza MMG, et al. The use of lidocaine as an anti-inflammatory substance: a systematic review. Journal of dentistry. 2009;37:93-97.

Van Der Wal S, Van Den Heuvel S, Radema S, V et al. The in vitro mechanisms and in vivo efficacy of intravenous lidocaine on the neuroinflammatory response in acute and chronic pain. European journal of pain. 2016;20:655-674.

Wallace MS, Laitin S, Licht D, et al. Concentration-effect relations for intravenous lidocaine infusions in human volunteers: effects on acute sensory thresholds and capsaicin-evoked hyperpathia. The Journal of the American Society of Anesthesiologists. 1997;86:1262-1272.

Koppert W, Zeck S, Sittl R, et al. Low-dose lidocaine suppresses experimentally induced hyperalgesia in humans. The Journal of the American Society of Anesthesiologists. 1998;89:1345-1353.

Koppert W, Ostermeier N, Sittl R, et al. Low‐dose lidocaine reduces secondary hyperalgesia by a central mode of action. Journal of the Peripheral Nervous System. 2000;5:238.

Wallace MS, Ridgeway BM, Leung AY, et al. Concentration–effect relationship of intravenous lidocaine on the allodynia of complex regional pain syndrome types I and II. The Journal of the American Society of Anesthesiologists. 2000;92:75.

Attal N, Gaude V, Brasseur L, et al. Intravenous lidocaine in central pain: a double-blind, placebo-controlled, psychophysical study. Neurology. 2000;54:564.

Challapalli V, Tremont-Lukats IW, McNicol ED, et al. Systemic administration of local anesthetic agents to relieve neuropathic pain. Cochrane Database of Systematic Reviews. 2005.

Finnerup NB, Biering-Sørensen F, Johannesen IL, et al. Intravenous lidocaine relieves spinal cord injury pain: a randomized controlled trial. The Journal of the American Society of Anesthesiologists. 2005;102:1023-1030.

Tremont-Lukats IW, Hutson PR, Backonja M-M. A randomized, double-masked, placebo-controlled pilot trial of extended IV lidocaine infusion for relief of ongoing neuropathic pain. The Clinical journal of pain. 2006;22:266-271.

Viola V, Newnham HH, Simpson RW. Treatment of intractable painful diabetic neuropathy with intravenous lignocaine. Journal of Diabetes and its Complications. 2006;20:34-39.

Moulin DE, Morley-Forster PK, Pirani Z, et al. Intravenous lidocaine in the management of chronic peripheral neuropathic pain: a randomized-controlled trial. Canadian Journal of Anesthesia. 2019:1-8.

Nguyen NL, Kome AM, Lowe DK, et al. Intravenous lidocaine as an adjuvant for pain associated with sickle cell disease. Journal of pain & palliative care pharmacotherapy. 2015;29:359-364.

Mooney JJ, Pagel PS, Kundu A. Safety, tolerability, and short-term efficacy of intravenous lidocaine infusions for the treatment of chronic pain in adolescents and young adults: a preliminary report. Pain Medicine. 2014;15:820-825.

Iolascon G. Is systemic administration of local anesthetic agents effective for relieving neuropathic pain? A Cochrane Review summary with commentary. NeuroRehabilitation. 2020;47:247-249.

Kocatürk Ö, Kocatürk M, İnan LE. SUNCT’ta İntravenöz Lidokain Kullanımı. Turkish Journal of Neurology. 2018;24:337-339.

Carroll IR, Younger JW, Mackey SC. Pain quality predicts lidocaine analgesia among patients with suspected neuropathic pain. Pain medicine. 2010;11:617-621.

Weibel S, Jelting Y, Pace NL, et al. Continuous intravenous perioperative lidocaine infusion for postoperative pain and recovery in adults. Cochrane Database of Systematic Reviews. 2018.

Foo I, Macfarlane A, Srivastava D, et al. The use of intravenous lidocaine for postoperative pain and recovery: international consensus statement on efficacy and safety. Anaesthesia. 2021;76:238-250.